Jazz Pharmaceuticals plc Common Stock (Ireland) (NASDAQ: JAZZ) last traded at $254.28, up 2.24% on the session. The quote above updates while this page is open; the figures below are drawn from Jazz Pharmaceuticals plc Common Stock (Ireland)’s own filings and are restated only when a new one is published.
Jazz Pharmaceuticals plc Common Stock (Ireland) trades on NASDAQ under the ticker JAZZ. Its market capitalisation is $16.51 billion.
Valuation measures for Jazz Pharmaceuticals plc Common Stock (Ireland), derived from the latest quote and its most recent SEC filing.
| Market cap | $16.51B |
|---|---|
| P/E ratio | 17.38 |
| Price / sales | 3.59 |
| Price / book | 3.44 |
| Beta | 0.46 |
Trailing-twelve-month figures tagged in Jazz Pharmaceuticals plc Common Stock (Ireland)'s XBRL filings with the SEC.
| Revenue (TTM) | $4.60B |
|---|---|
| Net income (TTM) | $940.75M |
| EPS (TTM) | $14.63 |
| Operating margin | 19.49% |
| Return on equity | 19.59% |
| Cash | $1.62B |
Range and volume for JAZZ over the past 52 weeks.
| 52-week high | $265.05 |
|---|---|
| 52-week low | $122.50 |
| Volume | 516.6K |
| Average volume | 821.4K |
| Previous close | $248.70 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.